HuGE Literature Finder
Records
1
-
6
| Association of chemokine and chemokine receptor polymorphisms with activity degree of IBD in Tunisian patients. Archives de l'Institut Pasteur de Tunis 2013 3 88 (1-4): 47-58. Gorgi Y, Ben Aleya W, Sfar I, Aounallah-Skhiri H, Mouelhi L, Jendoubi-Ayed S, Makhlouf M, Ben Rhomdhane T, Matri S, Filali A, Aouadi H, Najjar T, Ben Abdallah T, Ayed |
| CC-type chemokine receptor 5-Delta32 mutation protects against primary sclerosing cholangitis. Inflammatory bowel diseases 2006 Apr 12 (4): 272-7. Henckaerts Liesbet, Fevery Johan, Van Steenbergen Werner, Verslype Chris, Yap Paul, Nevens Frederik, Roskams Tania, Libbrecht Louis, Rutgeerts Paul, Vermeire Séveri |
| CCR5-Delta32 mutation is strongly associated with primary sclerosing cholangitis. Genes and immunity 2004 Sep 5 (6): 444-50. Eri R, Jonsson J R, Pandeya N, Purdie D M, Clouston A D, Martin N, Duffy D, Powell E E, Fawcett J, Florin T H J, Radford-Smith G |
| The CC chemokine receptor 5 delta32 mutation is not associated with inflammatory bowel disease (IBD) in NE England. Genes and immunity 2001 Apr 2 (2): 114-6. Craggs A, Welfare M, Donaldson P T, Mansfield J |
| Analysis of the CC chemokine receptor 5 (CCR5) delta-32 polymorphism in inflammatory bowel disease. Human genetics 2001 Mar 108 (3): 190-3. Rector A, Vermeire S, Thoelen I, Keyaerts E, Struyf F, Vlietinck R, Rutgeerts P, Van Ranst |
| Delta 32 mutation of the chemokine-receptor 5 gene in inflammatory bowel disease. Clinical immunology (Orlando, Fla.) 2001 Jan 98 (1): 18-22. Martin K, Heinzlmann M, Borchers R, Mack M, Loeschke K, Folwaczny |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: